News

Lung macrophages play a pivotal role in diseases like idiopathic pulmonary fibrosis. Two types of macrophages—the white blood ...
The University of Texas at Tyler was awarded a $219,000 grant to help fund a professor’s pulmonary fibrosis treatment project ...
Panelists discuss how emerging, better-tolerated oral therapies for idiopathic pulmonary fibrosis (IPF) and progressive ...
Post-COVID pulmonary fibrosis, which involves scarring of the lungs that can worsen over time and may require a lung transplant, affects some patients after infection, according to pulmonologists.
Pulmonary fibrosis is a rare, chronic disease that causes scarring in the lungs, making breathing difficult for people who suffer with it. And, as University of South Florida pulmonologist Dr ...
A Texas researcher received a $219,000 NIH grant to study the potential of a treatment for radiation-induced pulmonary ...
Pulmonary fibrosis (PF) is a progressive interstitial lung disease (ILD) characterised by excessive fibrotic tissue deposition in the pulmonary parenchyma. The term "pulmonary" refers to the lungs ...
Qureight used three deep learning models developed to quantify lung volume (Lung8), pulmonary vessel volume (Vascul8), and fibrosis extent (Fibr8) on the baseline and follow-up CTs of ENV-101 ...
One day after Boehringer Ingelheim presented so-so data from a successful trial of its highly touted idiopathic pulmonary fibrosis (IPF) candidate nerandomilast, PureTech has answered with results ...
Idiopathic pulmonary fibrosis is a progressive lung disorder characterised by lung scarring without any particular cause. According to StatPearls Publishing , the condition typically affects older ...
A year ago, there was 1 drug for idiopathic pulmonary fibrosis in trials at Temple Health. Now there are 10 active trials and 8 more coming up. 24/7 Live Philadelphia Pennsylvania New Jersey Delaware ...
Avalyn Presents Multiple Posters on AP01 for Pulmonary Fibrosis, Including MIST Phase 2b Trial Design and ATLAS Phase 1b Study Post-hoc Analyses, at ERS 2024 Avalyn Pharma Inc. Sun, Sep 8, 2024, 9 ...